- Josepine Fernow, Marie Olliver, William Couet, Sophie Lagrange, Meindert H. Lamers, Ole F. Olesen, Kristina Orrling, Michel Pieren, Derek J. Sloan, Juan José Vaquero, Timothy J. Miles & Anders Karlén. The AMR Accelerator: from individual organizations to efficient antibiotic development partnerships. Nature Reviews Drug Discovery. DOI: 10.1038/d41573-024-00138-9 (2024)
(This publication can be freely accessed from the journal’s website between 23 September and 6 October 2024. To access the article after 6 October without a subscription, please go to the AMR Accelerator website.) - Mio Tanaka, Anna O. Kildemoes, Evans Asena Chadeka, Benard Ngetich Cheruiyot, Miho Sassa, Taeko Moriyasu, Risa Nakamura, Mihoko Kikuchi, Yoshito Fujii, Claudia J. de Dood, Paul L.A.M. Corstjens, Satoshi Kaneko, Haruhiko Maruyama, Sammy M. Njenga, Remco de Vrueh, Cornelis H. Hokke, Shinjiro Hamano. Potential of antibody test using Schistosoma mansoni recombinant serpin and RP26 to detect light-intensity infections in endemic areas. Parasitology International, Volume 83, 2021, 102346 (2021)
- Hussaarts, L., van der Weijde, K., Dome, P., Kourany-Lefoll, E., Reinhard-Rupp, J., de Vrueh, R., & Pediatric Praziquantel Consortium. Drug research and development programs for neglected tropical diseases: A crucial role for expert meetings. PLOS Neglected Tropical Diseases 11. (2017)
- Kourany-Lefoll, E., & Keiser, J. & Vrueh de, R. Positive action: Pediatric Praziquantel Consortium. European Biopharmaceutical Rev. 10-15. (2015)
- Orrling KM, Verheij HJ, Leurs R. Fast track to new drugs. PEN: Science & Technology, 11, 194-195. (2014)
- Iyer, J.K., Janssen, J.W., Leurs, R., & Crommelin, D. Neglected no more. Fostering Innovation in the Neglected Diseases. Preclinical drug discovery. Genesis: 62. (2009)
